Head-to-head · Value Score
Found vs WellMedr
Two GLP-1 deals, scored on the same six factors. Found lands a Value Score of 78, WellMedr a 42. Here's who gives you the honest lower price — and where each one bites back.
Found
#62 · Grade B- · Fair Price
Est. first month
$289/mo cash month-to-month · $169/mo on a 12-month prepay
Save ~93% vs brand-nameWellMedr
#388 · Grade C · Watch List
Est. first month
Not published — no month-to-month rate appears anywhere on the site
The verdict
Found takes it on Value Score, 78 to 42 — an est. $289/mo cash month-to-month · $169/mo on a 12-month prepay first month, though we flag its pricing to watch. WellMedr isn't out of it: Readers who want one desk that can prescribe almost every GLP-1 format, including a low-dose line and the FDA-approved brands, and who will hold off on comparing the price until the intake produces an actual number.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Found | WellMedr |
|---|---|---|
| Value Score | 78 (B-) | 42 (C) |
| Est. first month | $289/mo cash month-to-month · $169/mo on a 12-month prepay | Not published — no month-to-month rate appears anywhere on the site |
| Save vs brand-name | ~93% | — |
| Semaglutide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay | Not published — only a starting-at floor tied to a 12-month plan |
| Tirzepatide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules | Not published — only a starting-at floor, on a cycle that is not a month |
| Both molecules | Yes | Yes |
| Pricing | Watch | Watch |
| Coverage | All 50 states | Not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Found
The widest medication bench in this ranking — compounded, brand-name and oral — priced off a membership whose $99 headline only holds if you commit for months.
Why it's a deal
- Widest medication list here: compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
- Flat pricing as the dose increases — a titration does not raise the monthly cost
- Bills insurance for the clinical visits; the site says most members pay under $30 per visit
- Runs a dedicated GLP-1 microdose program for people who want a lower starting dose
The fine print
- The $99/mo is a longer-plan floor, not a month-to-month rate — Found's own FAQ says its 3, 6 and 12-month plans are what keep the monthly cost down, so paying monthly costs more
- Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
- The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
- Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are
WellMedr
Almost every GLP-1 format on one desk — both molecules, oral and injectable, brand-name Ozempic and Zepbound, and a dedicated eight-SKU microdose line — sold on a "Starting At $59 a month" card whose own banner ties that figure to a twelve-month plan and whose own refund policy bills every 21 days.
Why it's a deal
- Almost every format a GLP-1 shopper might want, on one desk: compounded semaglutide and tirzepatide as both injections and oral formulations, FDA-approved Ozempic and Zepbound alongside them, and a dedicated eight-SKU microdose line blended with NAD+, B12, methionine, inositol, L-carnitine, magnesium or L-theanine — a genuine low-dose product line rather than a smaller amount of a standard plan
- The compounding caveat is on the pricing page rather than buried in a footer, and it is direct: "Compounded medications are regulated by state Boards of Pharmacy, but are not evaluated by the FDA for safety or efficacy", followed by explicit thyroid C-cell tumor and medullary thyroid carcinoma warnings and the symptoms to seek care for
- Both halves of the supply chain are named. The telehealth consent identifies OpenLoop Healthcare Partners, PC and its state professional corporations, OpenLoop Health, Inc. and Reliant MD Medical Associates PLLC as the prescribing group, and the privacy policy names Mycelium Pharmacy as the fulfillment pharmacy — so both "who prescribes" and "who dispenses" have a name attached rather than a category you cannot look up
- The tirzepatide card states "Same price regardless of dosage", so on that molecule titrating up would not raise the bill
- The testimonials carry their own disclaimer rather than passing as customers: "Inspired by real patient success stories in similar Telehealth programs", with WellMedr stating outright that the people shown are not its patients
- LegitScript Healthcare Merchant certified — seal 44552952 resolves while three invented control IDs return 403 — and clean against FDA's live warning-letter database under the brand, the operator Wellmedr LLC, the clinical group OpenLoop and the named pharmacy Mycelium, with a known positive control returning in the same pass
- Brand-name pricing is the one thing published plainly: Ozempic from $1,399 and Zepbound from $1,599, both labeled month-to-month
The fine print
- No month-to-month price is published anywhere for either compounded molecule. Both plan cards give a "Starting At" floor and both CTAs hand you to a medical intake before a figure is confirmed, so you supply a health history before you learn what you will be charged
- The card headed "Monthly Plan" and the banner on the same screen contradict each other. The card reads "Starting At $59 a month"; the banner reads "Lock In $200 OFF Every Month, or $59/mo on 12/month Plans — For Life", which makes $59 a twelve-month rate rather than a monthly one
- A month here is not a month, and WellMedr gives two different answers about how long it is. The plan cards say the medication ships every 4 weeks, which is 13 charges a year rather than 12 — about $769 a year at $59, roughly $64 a month, and about $1,291 at $99, roughly $108 a month. The refund and cancellation policy instead says the subscription "will automatically renew every 21 days", which is 17.4 charges a year: about $1,026, or roughly $85 a month, and about $1,721, or roughly $143 a month
- WellMedr's own refund policy refers to a price it never prints. Bundle refunds are prorated against "the regular (non-bundle) pricing", so a standing rate exists and is published on no page — while the trust bar at the top of every page advertises "Transparent pricing"
- The storefront publishes $0.00 for every GLP-1 product, including both brand names and all eight microdose SKUs. That is a placeholder set after the intake rather than a price, and it means the commerce layer carries no figure to check the marketing against — the one product on the site with a real catalog price is the testosterone SKU
- The 90-day money-back guarantee on the pricing page — "IF YOU DON'T LOSE WEIGHT IN 90 DAYS WE WILL REFUND 100% OF YOUR MONEY" — is hard to square with the refund policy, which states that "all subscription charges are final once processed" and issues a full refund only if a clinician finds you ineligible before a prescription is issued. The same policy page also sets two different cancellation deadlines, 48 hours before renewal in one section and 72 hours in another
- The microdose page headlines "ZERO Side Effects", subheaded "Zero side effct for 70%+ of members" (their spelling), with no source for the figure and no safety warning anywhere on that page — the thyroid C-cell and MTC warnings sit on the pricing page instead. Six of the eight microdose SKUs publish no price at all; the two that do read $199 a month
- Only the tirzepatide card promises "Same price regardless of dosage". The semaglutide card says nothing either way, so that molecule's dose basis is unstated rather than flat — do not assume it holds on both
- States served are not published. The FAQ's entire answer is "We are expanding rapidly — eligibility is checked during sign-up", so you cannot check coverage before starting an intake
- The fulfillment pharmacy is named, but only in the privacy policy. Mycelium Pharmacy appears there and nowhere on the marketing, pricing or product pages, which say "licensed U.S. pharmacies", "certified U.S. pharmacies" and "FDA-registered facilities" instead — so a buyer reading the pages that sell the product never learns who fills the prescription, and no 503A or 503B status is stated anywhere
- "FDA-regulated pharmacies" in the top bar is a claim about the facility, not about the drug: compounded semaglutide and tirzepatide are not FDA-approved and are not generic equivalents of Wegovy, Ozempic or Zepbound
- The marketing leans hard on celebrity and authority — Dr. Nowzaradan, Kevin O'Leary, Russell Wilson, Ray Lewis, Lexi Thompson, Christina Milian — beside a patient gallery the site itself labels as stock imagery from other programs
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Found is ranked on the Found alternatives ranking, and the same list for the other side is on alternatives to WellMedr.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.